To include your compound in the COVID-19 Resource Center, submit it here.

Androxal enclomiphene: Phase II data

The single-blind, U.S. Phase II ZA-204 trial in 48 evaluable men with morning testosterone levels of <350 ng/dL showed that once-daily Androxal

Read the full 224 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE